The Trump administration plans to stop paying subsidies to health insurance companies that helped to lower premiums for Medicare drug plans, the Wall Street Journal reports. This was reported by Qazaqyia.kz citing The Guardian.
The change will stop the estimated $3.6bn in subsidies that went to insurance companies this year, making the cost of prescription drug plans, known as Part D, more expensive for seniors starting next year, according to administration officials.
About 25 million Americans have Part D plans, but the change will not take effect until after the upcoming midterm elections.
Impact and Consequences
This decision could significantly affect Medicare beneficiaries, especially seniors with limited fixed incomes. Part D plans help cover drug costs, and the elimination of subsidies could lead to higher premiums. Since the change takes effect after the 2026 midterm elections, it also carries political weight.
Critics' Response
Health policy experts and Democrats have criticized the move, arguing it will limit seniors' access to medications. They say the subsidy cut will make it harder for many retirees to afford their prescriptions.
Conclusion
The Trump administration's decision could bring significant changes to the Medicare program. Seniors and their families should prepare for potential increases in drug costs in the coming months.